Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence

Fig. 1

Mutations linked to various types of HAEnCI and its impact on the various proteases and protease inhibitors of the fibrinolytic and kallikrein-kinin systems. ANGPT1 = angiopoietin-1 gene, B2R = bradykinin-2 receptor, C1-INH = C1 esterase inhibitor, FXII = coagulation factor XII gene, HMWK = high molecular weight kininogen, KNG1 = kininogen-1 gene, MYOF = myoferlin gene, PAI = plasminogen activator inhibitor, PLG = plasminogen gene, TIE2 = tyrosine-protein kinase, tPA = tissue plasminogen activator, scuPA = single-chain urokinase-type plasminogen activator, uPA = urokinase-type plasminogen activator, VEGF = vascular endothelial growth factor

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172